tiprankstipranks
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN

BioMarin Pharmaceutical (BMRN) Ownership - Who Owns BioMarin Pharmaceutical?

1,716 Followers

BioMarin Pharmaceutical (BMRN) Ownership Overview

The ownership structure of BioMarin Pharmaceutical (BMRN) stock is a mix of institutional, retail and individual investors. Approximately 98.82% of the company’s stock is owned by Institutional Investors, 0.88% is owned by Insiders and 0.30% is owned by Public Companies and Individual Investors.
0.88% Insiders
38.97% Mutual Funds
59.85% Other Institutional Investors
0.30% Public Companies and Individual Investors

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 11, 2023
Henry Fuchs
President, Worldwide R&d
Sold$1085040
Aug 10, 2023
Guyer Charles Greg
Evp, Chief Technical Officer
Sold$500088
Aug 09, 2023
George Eric Davis
Evp, Chief Legal Officer
Sold$983620
Aug 09, 2023Sold$882140

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2023Sold$240134
Sep 30, 2023Sold$316758
Sep 30, 2023Bought$358874
Sep 30, 2023Bought$14280141

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
18,406,539.00Institution9.77%1,737,577,281.60
17,057,779.00Institution9.06%1,610,254,337.60
15,868,430.00Institution8.42%1,497,979,792.00
14,153,503.00Institution7.51%1,336,090,683.20
10,644,025.00Institution5.65%1,004,795,960.00
6,697,338.00Institution3.56%632,228,707.20
5,962,701.00Institution3.17%562,878,974.40
5,735,397.00Institution3.04%541,421,476.80
5,368,030.00Institution2.85%506,742,032.00
4,643,343.00Institution2.47%438,331,579.20

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
15,868,430.00Institution8.42%1,497,979,792.00
10,644,025.00Institution5.65%1,004,795,960.00
6,697,338.00Institution3.56%632,228,707.20
5,368,030.00Institution2.85%506,742,032.00
4,643,343.00Institution2.47%438,331,579.20
3,644,666.00Institution1.93%344,056,470.40
2,338,529.00Institution1.24%220,757,137.60
1,923,368.00Institution1.02%181,565,939.20
1,757,133.00Institution0.93%165,873,355.20
1,732,919.00Institution0.92%163,587,553.60

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,897,384.00Institution3.13%480,341,927.00
4,272,284.00Institution2.27%347,977,532.00
2,666,415.00Institution1.42%217,179,502.00
1,511,512.00Institution0.80%139,693,939.00
1,511,512.00Institution0.80%139,693,939.00
1,648,580.00Institution0.88%134,276,841.00
1,271,700.00Institution0.68%120,048,480.00
1,156,942.00Institution0.61%109,215,324.80
1,305,005.00Institution0.69%106,292,657.00
881,561.00Institution0.47%81,473,867.62

FAQ

Who Owns BioMarin Pharmaceutical (BMRN)?
According to the latest TipRanks data, approximately 59.85% of the company's stock is held by institutional investors, 0.88% is held by insiders, and 0.30% is held by retail investors.
    What percentage of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 59.85% of BioMarin Pharmaceutical (BMRN) stock is held by institutional investors.
      What percentage of BioMarin Pharmaceutical (BMRN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 0.30% of BioMarin Pharmaceutical (BMRN) stock is held by retail investors.
        Who owns the most shares of BioMarin Pharmaceutical (BMRN)?
        Theofanis Kolokotrones owns the most shares of BioMarin Pharmaceutical (BMRN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis